Ledger.Open graph →
SEC Form D · filed December 17, 2020

Syros Pharmaceuticals, Inc

Offering
$121.6M
Sold
$90.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (37)

Peter Wirth · Cambridge, MADirectorJennifer B. Moser · LARKSPUR, CADirectorPierre H. Lecomte · LARKSPUR, CADirectorCharles Esserman · LARKSPUR, CADirectorPhilip Sharp · San Francisco, CADirectorJoon Chang · Stamford, CTDirectorScott Birnbaum · New York, NYDirectorDavid C. Roth · Cambridge, MAExecTyler Stowater · Colmbus, OHDirectorSrinivas Akkaraju · Cambridge, MADirectorRobin Sears · Columbus, OHDirectorJeremy G. Springhorn · Cambridge, MAExecJoseph G. Ferra, Jr · Cambridge, MAExecGerald G. Quirk · Cambridge, MAExecMarsha A. Fanucci · Cambridge, MADirectorJeremy G. Springhorn · Cambridge, MAExecEdward D. Wong · LARKSPUR, CAExecPeter Valenti · Colmbus, OHDirectorDrew D. Weilbacher · LARKSPUR, CADirectorRichard A. Young · Cambridge, MADirectorAmir Nashat · Cambridge, MADirectorEric C. Olson · Cambridge, MAExecM. H. Mullin · LARKSPUR, CAExec · DirectorJames L. O'Hara · LARKSPUR, CADirectorBrad Beasecker · Columbus, OHDirectorJoseph H. Coyne · Dripping Springs, TXExec · DirectorSue G. Eckhardt · Cambridge, MADirectorRichard Heinick · Columbus, OHExecIrena D. Blind · LARKSPUR, CAExecRichard Lindstrom · Columbus, OHExecWilliam D. Cooling · LARKSPUR, CADirectorNancy Simonian · Cambridge, MAExec · DirectorAmir Nashat · San Diego, CADirectorMark Alles · Cambridge, MADirectorPhilip Sharp · San Francisco, CADirectorGerald G. Quirk · Cambridge, MAExecJoseph G. Ferra, Jr · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗